Canadian application, no grantCanada
Prostate cancer markers
CA 2404149 A1 · Owner: Eastern Virginia Medical School · Inventors: Wright, George L. Jr.; Adam, Bao-Ling; Cazares, Lisa H.
Overview
Drawings and full text
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
This invention provides organic biomolecule markers (e.g. proteins) useful for the differentiating prostate cancer benign prostate hyperplasia, and a , negative diagnosis.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed March 19, 2001. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended March 19, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 19, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledMarch 19, 2001
GrantedNo grant recorded
Term endedMarch 19, 2021
Patent numberCA 2404149 A1
Classification (IPC)G01N27/62 +2 more
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.